Selank for stress and anxiety: what the science actually says

What did @stevieleaabberton actually say?

She didn't make a specific claim. This video is a community callout, not a product endorsement. She said selank "sounds amazing" for her self-described high cortisol, anxiety, and "self-diagnosed" ADHD, and asked other women in her demographic who've used it to share their experiences before she commits to a bulk order.

That framing matters. She's not telling anyone to take selank. She's crowdsourcing anecdotes, which is a different thing entirely, though not without its own problems. Anecdote-based peptide decisions are how people end up in trouble, and a comment section is not a clinical trial. To her credit, she explicitly said she'll "do her own research" on dosing before starting, which is at least the right instinct, even if the execution of that research will likely stay in the biohacking-influencer ecosystem rather than PubMed.

The peptide she's referring to, often spelled selank or selanc, is a synthetic heptapeptide developed in Russia in the 1990s. It is not FDA-approved in any form.

Does the science back this up?

There is legitimate preclinical and some limited clinical research on selank, mostly out of Russian and Eastern European institutions. The findings are genuinely interesting. But "interesting" and "proven" are not the same thing, and the evidence base is thin by Western clinical standards.

Selank is an analogue of the endogenous peptide tuftsin. Early animal studies and small human trials showed anxiolytic effects potentially linked to modulation of GABA receptors and upregulation of BDNF (brain-derived neurotrophic factor). Zozulya et al. (2008, CNS Drug Reviews) published one of the more cited reviews of selank's mechanism, noting effects on serotonin and dopamine metabolism in rodent models. A small Russian clinical trial (Semenova et al., 2010, Bulletin of Experimental Biology and Medicine) reported reduced anxiety in patients with generalized anxiety disorder, but the sample sizes were small and the trials weren't conducted under the methodological standards that Western regulators require for drug approval.

For the ADHD angle, the evidence is even thinner. There's theoretical overlap because BDNF plays a role in attention regulation, but connecting that to "selank helps ADHD" is a long causal chain built mostly on inference, not clinical data.

What did they get wrong (or right)?

She got the general vibe right: selank does have a real, if modest, scientific basis for its anxiolytic reputation. She didn't oversell it. She didn't say it cures anything. Asking for peer feedback before spending money on a peptide is actually more cautious behavior than most biohacking content on TikTok.

What's missing is context about what she's actually buying. Selank sold outside of Russia is not a pharmaceutical product. It's a research peptide, typically lyophilized powder in an unlicensed vial, with no standardized manufacturing oversight, no verified purity guarantee, and no regulated dosing protocol. The gap between "selank studied in a Russian clinical setting" and "selank powder I ordered online" is significant and rarely discussed in these communities.

Her mention of "high cortisol" also deserves scrutiny. She hasn't had a clinical cortisol workup described on screen. Feeling stressed is not the same as having elevated serum cortisol, and selank has not been studied as a cortisol-lowering agent in well-controlled human trials. Conflating stress symptoms with a hormonal imbalance, then selecting a peptide to address it, is a pattern that sidesteps actual diagnosis.

What should you actually know?

Selank is not approved by the FDA, TGA, or most Western regulatory bodies. It is classified as a research compound. That means if you're sourcing it outside of a licensed telehealth or compounding framework, you have no verified information about what's actually in the vial.

The anxiolytic research is real but limited. Most human data comes from small trials in Russia, published in journals with limited independent replication. That doesn't make them wrong, but it does mean you shouldn't treat the findings as settled science. Independent replication in larger, double-blind trials hasn't happened at scale.

If anxiety, stress, and attentional difficulties are genuinely affecting your daily functioning, a selank vial sourced from a research peptide supplier is not a substitute for clinical assessment. A proper anxiety workup, cortisol panel if clinically indicated, and ADHD evaluation from a licensed provider will give you actual data to work with. Peptides can be part of a broader conversation with a qualified clinician. They are not a first-line intervention, and a TikTok comment section is not a clinical consultation.